CompletedPhase 3

Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics

Tunisia1,400 participantsStarted 2014-01

Plain-language summary

Outpatients treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this matter. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency departement after the first line treatment of a renal colic investigating the recurrence of pain, the reconsultation rates and the admissions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 18 years old * Consenting to participate in the study * Patients treated in the ED for RC * No contraindications of NSAI treatment Exclusion Criteria: * Patients excluded from the first phase of the study * Contraindication of NSAI treatment * Patients non reachable by telephone call * Patients that did not receive or use the treatment

What they're measuring

Efficacity of oral NSAI (telephone call, asking for the recurrence of pain, the reconsultation rates and intervals and the need for other treatments)

Timeframe: seven days

Trial details

NCT IDNCT02304783

SponsorUniversity of Monastir

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06

View on ClinicalTrials.gov More Renal Colic trials